Firms

Remiges Ventures

Remiges Ventures

remigesventures.com

Biotechnology venture capital firm and company builder that develops early therapeutic discoveries into drug-development companies. Remiges sources intellectual property from Japanese academic institutions and biotechnology research, supports hypothesis validation and incubation, and leads early-stage financings alongside international investor syndicates. It provides scientific, clinical, business-development and board support, drawing on pharmaceutical networks and experienced company leaders to advance programs toward global development. Its portfolio includes neuroscience, optogenetic retinal gene therapy, gut-brain therapeutics, sensory medicine, oncology and other areas of biopharmaceutical innovation. The US parent works with RDiscovery, its distinct Japanese investment manager and incubator.

Founded
—
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Aki TobaruPartner
Kazuhiko NonomuraPartner
Kyoko MatsumotoSenior Associate
Linda LiVenture Partner
Mitsuhiko KawaiAdvisor
Naoki HirayamaInvestment Manager
Richard MeadowsAdvisor
Stephen GittoDirector of Finance
Stuart HwangVenture Partner
Taka KodaPartner
Taro InabaManaging Partner
Walter OlesiakOperating Partner

Co-investing

Abingworth LLP
Chiesi Ventures
JIC Venture Growth Investments
Novo Holdings
RiverVest Venture Partners

Investments

¥1.3B2026-04-15Restore VisionJIC Venture Growth Investments, Remiges Ventures
$115M2025-04-16Glycomineabrdn Inc., Advent Life Sciences, CTI Life Sciences Fund, Novo Holdings, Sanofi Ventures, Abingworth LLP, RiverVest Venture Partners, Remiges Ventures, Chiesi Ventures, Asahi Kasei Ventures, Sanderling Ventures
$25M2025-01-11ImmunisRemiges Ventures, JLS Fund, LifeSpan Vision Ventures
$9M2024-01-16Cyrano TherapeuticsRemiges Ventures, Lumira Ventures
¥1.87B2023-12-15Restore VisionRemiges Ventures, JIC Venture Growth Investments
$10M2022-01-06Viage TherapeuticsRemiges Ventures
$35M2021-06-23GlycomineAbingworth LLP, Sanofi Ventures, RiverVest Venture Partners, Remiges Ventures, Novo Holdings, Mission BioCapital, Chiesi Ventures, Sanderling Ventures
$—Unknown dateMyrodia TherapeuticsRemiges Ventures